(-)-catechin has been researched along with baicalein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arioka, S; Hinou, H; Nishimura, S; Sakagami, M; Takemoto, H; Togame, H; Uematsu, R; Yamaguchi, H | 1 |
| Hang, HC; Tsou, LK; Yount, JS | 1 |
2 other study(ies) available for (-)-catechin and baicalein
| Article | Year |
|---|---|
Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
Topics: Base Sequence; DNA Primers; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glycoproteins; Neuraminidase; Recombinant Proteins; Structure-Activity Relationship; Trypanosoma cruzi | 2010 |
Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.
Topics: Bacterial Proteins; Catechin; Dose-Response Relationship, Drug; Epithelial Cells; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Plant Extracts; Salmonella typhimurium; Structure-Activity Relationship; Tea | 2017 |